Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H O'hara

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Newsletter. Institute of Inter-American Affairs (U.S.). Health and Sanitation Division|March 19, 2010
Nurses in YanquilandH O'HARA
British Medical Journal|August 27, 2010
Radical Cure of Hernia: A New MethodH O'Hara
Alternative Therapies in Health and Medicine|December 3, 2008
The recovery of a child with autism spectrum disorder through biomedical interventionsNancy H O'Hara, Gail M Szakacs
The Journal of Pharmacy and Pharmacology|December 1, 1975
Proceedings: Ortho-effects in structure-activity studies; correlation of pie values of o- and p-substituents in acetanilideJ C Dearden, J H O'Hara
The Journal of Pharmacy and Pharmacology|December 1, 1976
Quantitative structure-analgesic activity studies of some alkyl derivatives of paracetamol (4-hydroxyacetanilide [proceeding]J C Dearden, J H O'Hara
Current Medical Research and Opinion|January 1, 1989
Comparative clinical trial of the tolerability, patient acceptability and efficacy of two transdermal glyceryl trinitrate patches ('Deponit' 5 and 'Transiderm-Nitro' 5) in patients with angina pectorisC Vallé-Jones, J O'Hara, H O'Hara
Cancer Journal (Sudbury, Mass.)|June 25, 2016
Molecular Triage Trials in Colorectal CancerMark H O'Hara, Stanley R Hamilton, Peter J O'Dwyer
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 16, 2023
Advancements in Systemic Therapy for Pancreatic CancerTimothy J Brown, Kim A Reiss, Mark H O'Hara
Cancer Cell|September 18, 2020
Challenges and Opportunities for Pancreatic Cancer ImmunotherapyAdham S Bear, Robert H Vonderheide, Mark H O'Hara
Translational Lung Cancer Research|May 23, 2017
Preclinical rationale for combining radiation therapy and immunotherapy beyond checkpoint inhibitors (i.e., CART)James P Flynn, Mark H O'Hara, Saumil J Gandhi
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Newsletter. Institute of Inter-American Affairs (U.S.). Health and Sanitation Division|March 19, 2010
Nurses in YanquilandH O'HARA
British Medical Journal|August 27, 2010
Radical Cure of Hernia: A New MethodH O'Hara
Alternative Therapies in Health and Medicine|December 3, 2008
The recovery of a child with autism spectrum disorder through biomedical interventionsNancy H O'Hara, Gail M Szakacs
The Journal of Pharmacy and Pharmacology|December 1, 1975
Proceedings: Ortho-effects in structure-activity studies; correlation of pie values of o- and p-substituents in acetanilideJ C Dearden, J H O'Hara
The Journal of Pharmacy and Pharmacology|December 1, 1976
Quantitative structure-analgesic activity studies of some alkyl derivatives of paracetamol (4-hydroxyacetanilide [proceeding]J C Dearden, J H O'Hara
Current Medical Research and Opinion|January 1, 1989
Comparative clinical trial of the tolerability, patient acceptability and efficacy of two transdermal glyceryl trinitrate patches ('Deponit' 5 and 'Transiderm-Nitro' 5) in patients with angina pectorisC Vallé-Jones, J O'Hara, H O'Hara
Cancer Journal (Sudbury, Mass.)|June 25, 2016
Molecular Triage Trials in Colorectal CancerMark H O'Hara, Stanley R Hamilton, Peter J O'Dwyer
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 16, 2023
Advancements in Systemic Therapy for Pancreatic CancerTimothy J Brown, Kim A Reiss, Mark H O'Hara
Cancer Cell|September 18, 2020
Challenges and Opportunities for Pancreatic Cancer ImmunotherapyAdham S Bear, Robert H Vonderheide, Mark H O'Hara
Translational Lung Cancer Research|May 23, 2017
Preclinical rationale for combining radiation therapy and immunotherapy beyond checkpoint inhibitors (i.e., CART)James P Flynn, Mark H O'Hara, Saumil J Gandhi
Pageof 7